Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02267967
Brief Title: Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

First Submitted : October 10, 2014
First Submitted that Met QC Criteria : October 15, 2014
First Posted : October 20, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 9, 2018
Last Update Posted : November 12, 2018 (Estimate)